Overview of Financial Results for FY2022 3rd Quarter
CMIC HOLDINGS Co., Ltd.
Jul 29, 2022
Copyright ©2020 CMIC Group - All Rights Reserved
CMIC Group Business
2
CMIC Group Network
25 group companies, 61sites (48 offices, 6 factories, 7 laboratories)
Japan: 12 companies
Overseas: 13 companies
China Korea | USA |
HongKong
Vietnam
Thailand
Malaysia
Singapore
Global : 14
(Plants : 2, Lab : 1)
Offices
Plants
Lab
Taiwan | |
Philippines | |
Japan : 47 | |
(Plants : 4, Labs : 6) | |
Australia | Offices |
Plants | |
Labs |
3
Change in reportable segment
From FY22, there will be two reportable segments: Pharmaceutical Solutions, which expands PVC models, and Healthcare Solutions, which contributes to the health of individuals through medical institutions and local governments, etc.
4
Focus Activities of Mid-term Management Plan (FY2022-25)
Evolution of healthcare business
Comprehensive support for disease prevention, treatment R&D, and marketing
Contribution to sustainable society through services with high social benefits
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
CMIC Holdings Co. Ltd. published this content on 29 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2022 06:54:05 UTC.